Growth of preimplantation embryos is influenced byThe cells of the mammalian preimplantation embryo (from the time of fertilization until the implantation of the blastocyst into the uterus) form the progenitor cells for all other cell lineages. The regulation of the growth and survival of the cells of the early embryo is, however, poorly understood. Mammalian preimplantation embryos develop in vitro with simple medium requirements and have no absolute requirement for exogenous vitamins, hormones, or growth factors. This contrasts with the absolute requirement of normal somatic cells for exogenous mitogens and survival factors. The continued mitoses of preimplantation embryo cells in the absence of exogenous growth factors implicates a role for endogenous, autocrine trophic factors, or the constitutive activation of signaling pathways in the early embryo. Several lines of evidence support a role for the former: (i) the rate of embryo development in vitro is density-dependent, with embryos growing in relatively small volumes (or in large groups) developing more successfully than those grown in large volumes (or individually) (1, 2); (ii) the synthesis by the preimplantation embryo of a number of growth factor ligands and their receptors (3-8); and (iii) the capacity of some exogenous growth factors to enhance embryo metabolism in vitro and to compensate for the adverse effects of culture in large medium volumes (1, 2, 9).Experimental partial deprivation of released autocrine trophic factors did not arrest the cell-cycle at given checkpoints (9). Rather, there was progressive loss of viability with increased cell death as embryos progressed past the 8-cell stage. This finding suggests that the autocrine factors may act as survival factors rather than classical growth factors (triggering progression through specific cell-cycle checkpoints). While several autocrine factors have been implicated, platelet-activating factor (PAF) 1 seems to be one of the first produced, being synthesized de novo by the embryo soon after fertilization (10, 11). Its actions are required by the mid-2-cell stage for normal rates of embryo survival (9).Despite this range of supportive data, there is limited direct evidence for the action of autocrine trophic factors in early embryo development. Transgenic and recombinant knock-out models have not generally been informative of the growth requirements of the early embryo prior to implantation. This may be due to extensive redundancy of regulatory pathways.